Market Place
Sourcing Support
Viz.ai Collaborates With Sanofi and Regeneron on COPD Care
21 May 2025 //
PRESS RELEASE
Saptalis Pharmaceuticals Launches Likmez® Oral Suspension
20 May 2025 //
BUSINESSWIRE
Fresenius Kabi Introduces Epinephrine Inj in Multi-Dose Vials
20 May 2025 //
BUSINESSWIRE
HHS lays out most favored nation pricing expectations
20 May 2025 //
FIERCE PHARMA
Ritedose Pharmaceuticals FDA Approve Albuterol Sulfate Inhalation
20 May 2025 //
PR NEWSWIRE
Fine, Kaplan and Black, R.P.C. Announce Class Action Settlements
19 May 2025 //
PR NEWSWIRE
Lupin receives USFDA approval for Rivaroxaban Tablets
19 May 2025 //
INDPHARMAPOST
Lupin to boost complex generics in US, EU; eyes India growth
19 May 2025 //
BUSINESS STD
Alembic Pharmaceuticals gets USFDA approval for Rivaroxaban Table
18 May 2025 //
INDPHARMAPOST
CASI Pharmaceuticals Announces Q1 2025 Results
16 May 2025 //
ACCESSWIRE
Caplin gets USFDA approval for Haloperidol Decanoate Injection
15 May 2025 //
INDPHARMAPOST
Kennedy clashes with lawmakers over vaccine comments
15 May 2025 //
REUTERS
Famar Acquires Sterile Manufacturing Site in Homburg, Germany
15 May 2025 //
PRESS RELEASE
Lupin launches Tolvaptan Tablets in the US
14 May 2025 //
EXPRESS PHARMA
Cipla CEO: Trump`s order benefits Generics
14 May 2025 //
ECONOMICTIMES
Cipla: US Govt Order Won`t Affect Indian Pharma Players
13 May 2025 //
ECONOMICTIMES
Trump`s drug price order raises alarm bells for Indian pharma
13 May 2025 //
ECONOMICTIMES
Zydus receives approval from FDA for Glatiramer Acetate Injection
13 May 2025 //
INDPHARMAPOST
India Rejects UK’s Drug Data Exclusivity Request
12 May 2025 //
ECONOMICTIMES
Biocon plans $150-million capex in two years
10 May 2025 //
ECONOMICTIMES
Zydus gets USFDA nod for generic drug to treat multiple sclerosis
10 May 2025 //
ECONOMICTIMES
U.S. Drug Spending Up 10.2% in 2024, Weight Loss Drugs Top Driver
09 May 2025 //
PR NEWSWIRE
Generic versions of key diabetic drug in market double in a month
09 May 2025 //
ECONOMICTIMES
Lupin gains USFDA nod for Raltegravir Tablets USP, 600 mg
09 May 2025 //
EXPRESSPHARMA
Takeda eyes upcoming launches as Vyvanse generics hit lingers
09 May 2025 //
FIERCE PHARMA
Zydus Receives Approval From FDA for Glatiramer Acetate Injection
08 May 2025 //
BUSINESSWIRE
Theravance Biopharma Reports Q1 2025 Financial Results and Update
08 May 2025 //
PR NEWSWIRE
Hikma Pharma to pay $50 million in narcolepsy drug antitrust case
08 May 2025 //
REUTERS
Careington Expands Products with New Prescription Savings Program
08 May 2025 //
PR NEWSWIRE
Viatris Reports Q1 2025 Results, Reaffirms 2025 Outlook
08 May 2025 //
PR NEWSWIRE
FDA Confirms Para IV Patent Litigation for Erivedge Capsule
07 May 2025 //
FDA
FDA Confirms Para IV Patent Litigation for Erleada Tablet
07 May 2025 //
FDA
FDA Confirms Para IV Patent Litigation for Fotivda Capsules
07 May 2025 //
FDA
Zentiva Joins Call to Action for Pharmaceutical Reform in Europe
07 May 2025 //
PR NEWSWIRE
Abbott, Real Madrid Start Search to Empower Young Soccer Talent
07 May 2025 //
PR NEWSWIRE
Endo Reports Q1 2025 Results, Reaffirms 2025 Guidance
07 May 2025 //
PR NEWSWIRE
Viatris Announces Quarterly Dividend
07 May 2025 //
PR NEWSWIRE
Trump`s orders may impact Indian Pharma exports: Report
07 May 2025 //
ECONOMICTIMES
Sunshine Biopharma Launches Generic Lurasidone for Schizophrenia
06 May 2025 //
ACCESSWIRE
Formosa Pharmaceuticals Licenses Clobetasol Propionate to Apotex
06 May 2025 //
PR NEWSWIRE
Class Action Over Generic Clobetasol And Clomipramine
06 May 2025 //
PR NEWSWIRE
Senores Pharmaceuticals acquires ANDA for Topiramate HCl tablets
06 May 2025 //
INDPHARMAPOST
Alembic gets USFDA final approval for Ticagrelor Tablets
05 May 2025 //
INDPHARMAPOST
Gland Pharma gets USFDA approval for Latanoprostene Buno
02 May 2025 //
INDPHARMAPOST
Strides Pharma gets USFDA approval for Celecoxib Capsules
01 May 2025 //
PRESS RELEASE
MotoAmerica First to Use Abbott`s Rapid Blood Test for Concussion
01 May 2025 //
PR NEWSWIRE
Zydus Lifesciences approved by USFDA for generic cholesterol Drug
30 Apr 2025 //
ECONOMICTIMES
Strides acquires identified ANDAs from Nostrum Laboratories
29 Apr 2025 //
PRESS RELEASE
Morepen Labs gets CDSCO clearance for Resmetirom studies
29 Apr 2025 //
EXPRESSPHARMA
Navamedic ASA: Imdur® distribution agreement extended to 2032
29 Apr 2025 //
PR NEWSWIRE
Abbott Highlights New AVEIR™ Data, Initiates Trial for Conduction
27 Apr 2025 //
PR NEWSWIRE
BMS Reports Mixed Earnings as Portfolio due to Generic Pressure
26 Apr 2025 //
BIOSPACE
Lupin receives US FDA approval for generic Tolvaptan Tablets
25 Apr 2025 //
EXPRESSPHARMA
Novo protects US patients with legal wins against compounder
25 Apr 2025 //
PR NEWSWIRE
Nordic Group`s Subsidiary Launches Authorized Generic of Maxitrol
24 Apr 2025 //
PR NEWSWIRE
West Announces Q1 2025 Results, Raises EPS Guidance
24 Apr 2025 //
PR NEWSWIRE
Caplin Steriles approved by USFDA for Phytonadione Injectable
24 Apr 2025 //
INDPHARMAPOST
Aurobindo arm gets USFDA nod for generic blood cancer drug
24 Apr 2025 //
ECONOMICTIMES
J&J & Lilly Concealed Breast Cancer Risks in Antipsychotics Drug
24 Apr 2025 //
PR NEWSWIRE
US generic drugs could get battered by tariffs, USP chief warns
24 Apr 2025 //
FIERCE PHARMA
